Linklaters has advised EIC Fund on its participation to the Series C fundraising of CorWave, a French-based company developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on a breakthrough technology, the wave membrane pump.
This funding round of €35 million involved CorWave’s existing shareholders as well as leading investors in the life sciences sector, such as Bpifrance, Novo Holdings, Seventure, Sofinnova Partners and Ysios Capital, and also new investors, including EIC Fund.
CorWave is now the first private company to date to count the European Commission amongst its shareholders, with the first investment of EIC Fund, a fund with €3.6 billion resources to deploy, which brings €15 million to this funding round.
Linklaters team in Paris was led by Darko Adamovic, Energy & Infrastructures partner, and comprised of Corporate team members Mehdi Boumedine, managing associate, and Margaux Sartre, associate.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
